Human CD4+ CD25+ regulatory T lymphocytes inhibit lipopolysaccharide-induced monocyte survival through a Fas/Fas ligand-dependent mechanism

F Venet, A Pachot, AL Debard, J Bohe… - The Journal of …, 2006 - journals.aai.org
F Venet, A Pachot, AL Debard, J Bohe, J Bienvenu, A Lepape, WS Powell, G Monneret
The Journal of Immunology, 2006journals.aai.org
Although it is known that septic shock induces immunosuppression, the mechanism for this
phenomenon is not well understood. Monocytes play a central role in septic shock
pathophysiology, which is also characterized by an increased proportion of natural
regulatory T (Treg) cells. We therefore investigated whether Treg could be involved in the
decreased monocyte expression of CD14 and HLA-DR observed during septic shock. We
demonstrated that human Treg inhibit LPS-induced retention of monocyte CD14. Because …
Abstract
Although it is known that septic shock induces immunosuppression, the mechanism for this phenomenon is not well understood. Monocytes play a central role in septic shock pathophysiology, which is also characterized by an increased proportion of natural regulatory T (Treg) cells. We therefore investigated whether Treg could be involved in the decreased monocyte expression of CD14 and HLA-DR observed during septic shock. We demonstrated that human Treg inhibit LPS-induced retention of monocyte CD14. Because loss of CD14 is a hallmark of monocyte apoptosis, this suggests that Treg inhibit monocyte survival. This effect was largely mediated through the release of a soluble mediator that was not identical with either IL-10 or IL-4. The Fas/FasL pathway participated in the effect as it was blocked by anti-FasL Abs and reproduced by Fas agonist and recombinant soluble FasL. Furthermore, expression of FasL was much higher on Treg than on their CD25− counterparts. Collectively, these results indicate that Treg act on monocytes by inhibiting their LPS-induced survival through a proapoptotic mechanism involving the Fas/FasL pathway. This may be an important mechanism for septic shock-induced immunosuppression and may offer new perspectives for the treatment of this deadly disease.
journals.aai.org